NYSEAMERICAN:MYO Myomo (MYO) Stock Price, News & Analysis → An utter travesty (From The Freeport Society) (Ad) Free MYO Stock Alerts $3.39 -0.08 (-2.31%) (As of 10:46 AM ET) Add Compare Share Share Today's Range$3.33▼$3.4450-Day Range N/A52-Week Range$0.47▼$5.58Volume61,699 shsAverage Volume325,760 shsMarket Capitalization$97.70 millionP/E RatioN/ADividend YieldN/APrice Target$6.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest Get Myomo alerts: Email Address Myomo MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside99.1% Upside$6.75 Price TargetShort InterestHealthy3.61% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$350,000 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.18) to $0.01 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.89 out of 5 stars 3.5 Analyst's Opinion Consensus RatingMyomo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMyomo has only been the subject of 2 research reports in the past 90 days.Read more about Myomo's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.61% of the float of Myomo has been sold short.Short Interest Ratio / Days to CoverMyomo has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Myomo has recently increased by 14.70%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMyomo does not currently pay a dividend.Dividend GrowthMyomo does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MYO. Previous Next 1.1 News and Social Media Coverage Search Interest5 people have searched for MYO on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Myomo to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Myomo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $350,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 4.54% of the stock of Myomo is held by insiders.Percentage Held by Institutions44.99% of the stock of Myomo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Myomo's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Myomo are expected to grow in the coming year, from ($0.18) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Myomo is -12.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Myomo is -12.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMyomo has a P/B Ratio of 9.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Freeport SocietyA Silent Invasion of AmericaThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. About Myomo Stock (NYSEAMERICAN:MYO)Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.Read More MYO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MYO Stock News HeadlinesJune 1, 2024 | insidertrades.comMyomo, Inc. (NYSEAMERICAN:MYO) Director Thomas F. Kirk Buys 50,000 SharesJune 5, 2024 | businesswire.comMyomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024May 17, 2024 | finance.yahoo.comInsider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO)May 13, 2024 | finance.yahoo.comMYO: Myomo is Driving Advancements in Wearable TechnologyMay 10, 2024 | finance.yahoo.comMyomo Inc (MYO) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid Financial ...May 10, 2024 | finance.yahoo.comMyomo Inc Reports Q1 2024 Earnings: Revenue Up Despite ChallengesMay 9, 2024 | finance.yahoo.comMyomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call TranscriptMay 8, 2024 | investorplace.comMYO Stock Earnings: Myomo Meets EPS, Misses Revenue for Q1 2024May 8, 2024 | finance.yahoo.comMyomo Reports First Quarter 2024 Financial ResultsMay 7, 2024 | markets.businessinsider.comMyomo is about to announce its earnings — here's what Wall Street expectsMay 6, 2024 | finance.yahoo.comMyomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS FeesMay 2, 2024 | finance.yahoo.comMyomo, Inc. (MYO) Stock Price, News, Quote & History - Yahoo FinanceMay 1, 2024 | businesswire.comMyomo to Report First Quarter Financial Results on May 8, 2024April 20, 2024 | finance.yahoo.comMyomo, Inc. (MYO)March 30, 2024 | investing.comMyomo appoints Heather Getz to board of directorsMarch 28, 2024 | businesswire.comMyomo Appoints Heather Getz to its Board of DirectorsMarch 28, 2024 | businesswire.comMyomo Appoints Heather Getz to its Board of DirectorsMarch 18, 2024 | ca.sports.yahoo.comColby Covington reacts to Jorge Masvidal vs. Nate Diaz boxing match: ‘Sloppy, old f*cking dudes’March 18, 2024 | finance.yahoo.comDirector Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO)March 13, 2024 | seekingalpha.comMyomo's Revolutionary MyoPro Brace: A Buy In Neurological Mobility AidMarch 10, 2024 | seekingalpha.comMyomo, Inc.: In Motion To Accelerating Revenue GrowthMarch 9, 2024 | seekingalpha.comMyomo, Inc. (MYO) Q4 2023 Earnings Call TranscriptMarch 9, 2024 | markets.businessinsider.comMyomo Inc.: Strong Growth and Regulatory Tailwinds Support Buy RatingMarch 8, 2024 | finance.yahoo.comMyomo, Inc. (AMEX:MYO) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | investorplace.comMYO Stock Earnings: Myomo Misses EPS, Misses Revenue for Q4 2023See More Headlines Receive MYO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Myomo and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today6/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSEAMERICAN:MYO CUSIPN/A CIK1369290 Webmyomo.com Phone(617) 996-9058FaxN/AEmployees101Year FoundedN/APrice Target and Rating Average Stock Price Target$6.75 High Stock Price Target$7.00 Low Stock Price Target$6.50 Potential Upside/Downside+94.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,150,000.00 Net Margins-47.77% Pretax Margin-46.77% Return on Equity-94.02% Return on Assets-60.79% Debt Debt-to-Equity RatioN/A Current Ratio2.83 Quick Ratio2.40 Sales & Book Value Annual Sales$19.24 million Price / Sales5.20 Cash FlowN/A Price / Cash FlowN/A Book Value$0.34 per share Price / Book10.21Miscellaneous Outstanding Shares28,820,000Free Float27,507,000Market Cap$100.01 million OptionableNot Optionable Beta1.45 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Paul R. Gudonis (Age 69)Chairman, President & CEO Comp: $526.56kMr. David A. Henry (Age 63)Chief Financial Officer Comp: $401.56kDr. Harry Kovelman M.D. (Age 65)Chief Medical Officer Comp: $426.03kColin AndersonGlobal Director of OperationsMr. Joseph ChicoskieDirector of MarketingMs. Galina ShtivelmanSenior Director of Human ResourcesMr. Micah J. Mitchell (Age 48)Chief Commercial Officer Comp: $317.39kMore ExecutivesKey CompetitorsJin Medical InternationalNASDAQ:ZJYLSanara MedTechNASDAQ:SMTIInogenNASDAQ:INGNLakeland IndustriesNASDAQ:LAKENutribandNASDAQ:NTRBView All CompetitorsInsiders & InstitutionsThomas F KirkBought 50,000 shares on 5/29/2024Total: $175,000.00 ($3.50/share)Herr Investment Group LLCBought 665,330 shares on 5/14/2024Ownership: 5.711%Vanguard Group Inc.Sold 51,437 shares on 5/10/2024Ownership: 4.049%PFG AdvisorsBought 20,016 shares on 5/7/2024Ownership: 0.162%Essex Investment Management Co. LLCBought 508,249 shares on 5/3/2024Ownership: 2.093%View All Insider TransactionsView All Institutional Transactions MYO Stock Analysis - Frequently Asked Questions Should I buy or sell Myomo stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MYO shares. View MYO analyst ratings or view top-rated stocks. What is Myomo's stock price target for 2024? 2 brokerages have issued 12-month price targets for Myomo's shares. Their MYO share price targets range from $6.50 to $7.00. On average, they anticipate the company's stock price to reach $6.75 in the next twelve months. This suggests a possible upside of 99.1% from the stock's current price. View analysts price targets for MYO or view top-rated stocks among Wall Street analysts. How have MYO shares performed in 2024? Myomo's stock was trading at $4.74 at the beginning of the year. Since then, MYO shares have decreased by 28.5% and is now trading at $3.39. View the best growth stocks for 2024 here. How were Myomo's earnings last quarter? Myomo, Inc. (NYSEAMERICAN:MYO) posted its earnings results on Wednesday, May, 8th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.09) by $0.01. The business earned $3.75 million during the quarter. Myomo had a negative net margin of 47.77% and a negative trailing twelve-month return on equity of 94.02%. What guidance has Myomo issued on next quarter's earnings? Myomo updated its second quarter 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $5.0 million-, compared to the consensus revenue estimate of $5.1 million. What other stocks do shareholders of Myomo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Myomo investors own include Genocea Biosciences (GNCA), Agile Therapeutics (AGRX), Sarepta Therapeutics (SRPT), Aclaris Therapeutics (ACRS), Remark (MARK), Synergy Pharmaceuticals (SGYP), VBI Vaccines (VBIV), Athersys (ATHX) and Anavex Life Sciences (AVXL). Who are Myomo's major shareholders? Myomo's stock is owned by many different retail and institutional investors. Top institutional investors include Rosalind Advisors Inc. (8.59%), Herr Investment Group LLC (5.71%), Vanguard Group Inc. (4.05%), Essex Investment Management Co. LLC (2.09%), PFG Advisors (0.16%) and Accel Wealth Management (0.15%). Insiders that own company stock include David A Henry, Harry Kovelman, Micah Mitchell, Milton Mayo Morris, Paul R Gudonis, Thomas Aloysius Jr Crowley and Thomas F Kirk. View institutional ownership trends. How do I buy shares of Myomo? Shares of MYO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:MYO) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myomo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myomo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.